人类造血干细胞在淋巴样前体多能祖细胞之前就发生髓系-淋巴系谱系限制。
Myelo-lymphoid lineage restriction occurs in the human haematopoietic stem cell compartment before lymphoid-primed multipotent progenitors.
机构信息
Department of Haematology and Wellcome and MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
出版信息
Nat Commun. 2018 Oct 5;9(1):4100. doi: 10.1038/s41467-018-06442-4.
Capturing where and how multipotency is lost is crucial to understand how blood formation is controlled. Blood lineage specification is currently thought to occur downstream of multipotent haematopoietic stem cells (HSC). Here we show that, in human, the first lineage restriction events occur within the CD19CD34CD38CD45RACD49fCD90 (49f) HSC compartment to generate myelo-lymphoid committed cells with no erythroid differentiation capacity. At single-cell resolution, we observe a continuous but polarised organisation of the 49f compartment, where transcriptional programmes and lineage potential progressively change along a gradient of opposing cell surface expression of CLEC9A and CD34. CLEC9ACD34 cells contain long-term repopulating multipotent HSCs with slow quiescence exit kinetics, whereas CLEC9ACD34 cells are restricted to myelo-lymphoid differentiation and display infrequent but durable repopulation capacity. We thus propose that human HSCs gradually transition to a discrete lymphoid-primed state, distinct from lymphoid-primed multipotent progenitors, representing the earliest entry point into lymphoid commitment.
捕捉多能性丧失的位置和方式对于理解血液形成如何受到控制至关重要。目前认为,血液谱系特化发生在多能造血干细胞(HSC)下游。在这里,我们表明,在人类中,第一个谱系限制事件发生在 CD19CD34CD38CD45RACD49fCD90(49f)HSC 隔室中,产生没有红细胞分化能力的骨髓-淋巴系定向细胞。在单细胞分辨率下,我们观察到 49f 隔室的连续但极化组织,其中转录程序和谱系潜能沿着 CLEC9A 和 CD34 细胞表面表达相反的梯度逐渐变化。CLEC9ACD34 细胞包含具有缓慢静止退出动力学的长期重编程多能 HSC,而 CLEC9ACD34 细胞仅限于骨髓-淋巴系分化,并显示出罕见但持久的重编程能力。因此,我们提出人类 HSC 逐渐过渡到离散的淋巴样前体状态,与淋巴样前体多能祖细胞不同,代表进入淋巴样定向的最早切入点。